인간면역결핍바이러스(HIV) 신속 검사 키트 시장(2026-2030년)

The global human immunodeficiency virus (HIV) rapid test kits market is forecasted to grow by USD 364.8 mn during 2025-2030, accelerating at a CAGR of 7.1% during the forecast period. The report on the global human immunodeficiency virus (HIV) rapid test kits market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by progressive expansion of patient-led decentralized screening architecture, transition to advanced fourth-generation multiplex assays and dual testing formats, accelerated technological transition toward advanced fourth-generation multiplex assays.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global human immunodeficiency virus (HIV) rapid test kits market is segmented as below:

By Distribution Channel

• Offline
• Online

By Type

• HIV rapid immunoassay test
• HIV rapid molecular diagnostic test

By End-User

• Diagnostic centers
• Hospitals and clinics

By Source

• Blood
• Oral fluids
• Urine

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the proliferation of digital health ecosystems and ai-assisted results interpretation as one of the prime reasons driving the global human immunodeficiency virus (HIV) rapid test kits market growth during the next few years. Also, shifting preferences toward multiplex rapid diagnostic platforms for integrated screening and expansion of non-invasive oral fluid and advanced sample collection methodologies will lead to sizable demand in the market.

The report on the global human immunodeficiency virus (HIV) rapid test kits market covers the following areas:

• Global human immunodeficiency virus (HIV) rapid test kits market sizing
• Global human immunodeficiency virus (HIV) rapid test kits market forecast
• Global human immunodeficiency virus (HIV) rapid test kits market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global human immunodeficiency virus (HIV) rapid test kits market vendors that include Abbott Laboratories, AccuQuik Test Kits, Amkay Products Pvt. Ltd., Becton Dickinson and Co., Bhat Bio Tech India Pvt Ltd., Biolytical Laboratories Inc., BioMerieux SA, Chembio Diagnostics Inc., Danaher Corp., DrSafeHands, F. Hoffmann La Roche Ltd., Fujirebio Holdings Inc., Hologic Inc., J. Mitra and Co. Pvt. Ltd., Healgen Scientific, LLC, MP Biomedicals Inc., OraSure Technologies Inc., Pathkits, Trinity Biotech Plc. Also, the global human immunodeficiency virus (HIV) rapid test kits market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Source
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2020 - 2024
  • Historic Market Size - Data Table on Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2020 - 2024 ($ million)
• 5.2 Distribution Channel segment analysis 2020 - 2024
  • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
• 5.3 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Source segment analysis 2020 - 2024
  • Historic Market Size - Source Segment 2020 - 2024 ($ million)
• 5.6 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.7 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI in Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market
• 6.2 Impact of geopolitical conflict on Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Distribution Channel

• 8.1 Market segments
• 8.2 Comparison by Distribution Channel
• 8.3 Offline - Market size and forecast 2025-2030
• 8.4 Online - Market size and forecast 2025-2030
• 8.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)

9 Market Segmentation by Type

• 9.1 Market segments
• 9.2 Comparison by Type
• 9.3 HIV rapid immunoassay test - Market size and forecast 2025-2030
• 9.4 HIV rapid molecular diagnostic test - Market size and forecast 2025-2030
• 9.5 Market opportunity by Type
  • Market opportunity by Type ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Diagnostic centers - Market size and forecast 2025-2030
• 10.4 Hospitals and clinics - Market size and forecast 2025-2030
• 10.5 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Market Segmentation by Source

• 11.1 Market segments
• 11.2 Comparison by Source
• 11.3 Blood - Market size and forecast 2025-2030
• 11.4 Oral fluids - Market size and forecast 2025-2030
• 11.5 Urine - Market size and forecast 2025-2030
• 11.6 Market opportunity by Source
  • Market opportunity by Source ($ million)

12 Customer Landscape

• 12.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

• 13.1 Geographic segmentation
• 13.2 Geographic comparison
• 13.3 North America - Market size and forecast 2025-2030
  • 13.3.1 US - Market size and forecast 2025-2030
  • 13.3.2 Canada - Market size and forecast 2025-2030
  • 13.3.3 Mexico - Market size and forecast 2025-2030
• 13.4 Europe - Market size and forecast 2025-2030
  • 13.4.1 Germany - Market size and forecast 2025-2030
  • 13.4.2 UK - Market size and forecast 2025-2030
  • 13.4.3 France - Market size and forecast 2025-2030
  • 13.4.4 Italy - Market size and forecast 2025-2030
  • 13.4.5 Spain - Market size and forecast 2025-2030
  • 13.4.6 The Netherlands - Market size and forecast 2025-2030
• 13.5 Asia - Market size and forecast 2025-2030
  • 13.5.1 China - Market size and forecast 2025-2030
  • 13.5.2 India - Market size and forecast 2025-2030
  • 13.5.3 Japan - Market size and forecast 2025-2030
  • 13.5.4 South Korea - Market size and forecast 2025-2030
  • 13.5.5 Indonesia - Market size and forecast 2025-2030
  • 13.5.6 Thailand - Market size and forecast 2025-2030
• 13.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 13.6.1 South Africa - Market size and forecast 2025-2030
  • 13.6.2 Brazil - Market size and forecast 2025-2030
  • 13.6.3 Argentina - Market size and forecast 2025-2030
  • 13.6.4 Saudi Arabia - Market size and forecast 2025-2030
  • 13.6.5 Colombia - Market size and forecast 2025-2030
  • 13.6.6 UAE - Market size and forecast 2025-2030
  • 13.6.7 Turkey - Market size and forecast 2025-2030
  • 13.6.8 Israel - Market size and forecast 2025-2030
• 13.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

14 Drivers, Challenges, and Opportunity

• 14.1 Market drivers
  • Progressive expansion of patient-led decentralized screening architecture
  • Transition to advanced fourth-generation multiplex assays and dual testing formats
  • Accelerated technological transition toward advanced fourth-generation multiplex assays
• 14.2 Market challenges
  • Strict and fragmented regional regulatory approval processes
  • Supply chain vulnerabilities and specialized logistics bottlenecks
  • Stigma, social barriers, and low linkage to confirmatory medical care
• 14.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 14.4 Market opportunities
  • Proliferation of digital health ecosystems and AI-assisted results interpretation
  • Shifting preferences toward multiplex rapid diagnostic platforms for integrated screening
  • Expansion of non-invasive oral fluid and advanced sample collection methodologies

15 Competitive Landscape

• 15.1 Overview
• 15.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 15.3 Landscape disruption
  • Overview on factors of disruption
• 15.4 Industry risks
  • Impact of key risks on business

16 Competitive Analysis

• 16.1 Companies profiled
  • Companies covered
• 16.2 Company ranking index
  • Company ranking index
• 16.3 Market positioning of companies
  • Matrix on companies position and classification
• 16.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 16.5 Amkay Products Pvt. Ltd.
  • Amkay Products Pvt. Ltd. - Overview
  • Amkay Products Pvt. Ltd. - Product / Service
  • Amkay Products Pvt. Ltd. - Key offerings
  • SWOT
• 16.6 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 16.7 Bhat Bio Tech India Pvt Ltd.
  • Bhat Bio Tech India Pvt Ltd. - Overview
  • Bhat Bio Tech India Pvt Ltd. - Product / Service
  • Bhat Bio Tech India Pvt Ltd. - Key offerings
  • SWOT
• 16.8 BioMerieux SA
  • BioMerieux SA - Overview
  • BioMerieux SA - Business segments
  • BioMerieux SA - Key offerings
  • BioMerieux SA - Segment focus
  • SWOT
• 16.9 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
  • SWOT
• 16.10 DrSafeHands
  • DrSafeHands - Overview
  • DrSafeHands - Product / Service
  • DrSafeHands - Key offerings
  • SWOT
• 16.11 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
  • SWOT
• 16.12 Fujirebio Holdings Inc.
  • Fujirebio Holdings Inc. - Overview
  • Fujirebio Holdings Inc. - Product / Service
  • Fujirebio Holdings Inc. - Key offerings
  • SWOT
• 16.13 Hologic Inc.
  • Hologic Inc. - Overview
  • Hologic Inc. - Product / Service
  • Hologic Inc. - Key offerings
  • SWOT
• 16.14 J. Mitra and Co. Pvt. Ltd.
  • J. Mitra and Co. Pvt. Ltd. - Overview
  • J. Mitra and Co. Pvt. Ltd. - Product / Service
  • J. Mitra and Co. Pvt. Ltd. - Key offerings
  • SWOT
• 16.15 Healgen Scientific, LLC
  • Healgen Scientific, LLC - Overview
  • Healgen Scientific, LLC - Product / Service
  • Healgen Scientific, LLC - Key offerings
  • SWOT
• 16.16 MP Biomedicals Inc.
  • MP Biomedicals Inc. - Overview
  • MP Biomedicals Inc. - Product / Service
  • MP Biomedicals Inc. - Key offerings
  • SWOT
• 16.17 OraSure Technologies Inc.
  • OraSure Technologies Inc. - Overview
  • OraSure Technologies Inc. - Business segments
  • OraSure Technologies Inc. - Key offerings
  • OraSure Technologies Inc. - Segment focus
  • SWOT
• 16.18 Trinity Biotech Plc
  • Trinity Biotech Plc - Overview
  • Trinity Biotech Plc - Product / Service
  • Trinity Biotech Plc - Key offerings
  • SWOT

17 Appendix

• 17.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 17.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 17.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 17.4 Research methodology
  • Research methodology
• 17.5 Data procurement
  • Information sources
• 17.6 Data validation
  • Data validation
• 17.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 17.8 Data synthesis
  • Data synthesis
• 17.9 360 degree market analysis
  • 360 degree market analysis
• 17.10 List of abbreviations
  • List of abbreviations